Since TUSC2 expression is inhibited by miRNAs across multiple cancer types, developing a nanoparticle carrying a TUSC2P expression vector may result in increased TUSC2 protein expression through sequestration of the TUSC2-targeting miRNAs. Here, TUSC2 is linked to cancer.